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Abstract
Protease activated receptor-1 (PAR1) is expressed in multiple cell types in the CNS, with the most prominent
expression in glial cells. PAR1 activation enhances excitatory synaptic transmission secondary to the release of
glutamate from astrocytes following activation of astrocytically-expressed PAR1. In addition, PAR1 activation
exacerbates neuronal damage in multiple in vivo models of brain injury in a manner that is dependent on NMDA
receptors. In the hippocampal formation, PAR1 mRNA appears to be expressed by a subset of neurons, including
granule cells in the dentate gyrus. In this study we investigate the role of PAR activation in controlling neuronal
excitability of dentate granule cells. We confirm that PAR1 protein is expressed in neurons of the dentate cell body
layer as well as in astrocytes throughout the dentate. Activation of PAR1 receptors by the selective peptide agonist
TFLLR increased the intracellular Ca2+ concentration in a subset of acutely dissociated dentate neurons as well as
non-neuronal cells. Bath application of TFLLR in acute hippocampal slices depolarized the dentate gyrus, including
the hilar region in wild type but not in the PAR1-/- mice. PAR1 activation increased the frequency of action
potential generation in a subset of dentate granule neurons; cells in which PAR1 activation triggered action
potentials showed a significant depolarization. The activation of PAR1 by thrombin increased the amplitude of
NMDA receptor-mediated component of EPSPs. These data suggest that activation of PAR1 during normal function
or pathological conditions, such as during ischemia or hemorrhage, can increase the excitability of dentate granule
cells.
Background
Protease activated receptor 1 (PAR1) is a G-protein
coupled receptor that is best known for its role in coa-
gulation and homeostasis [1-3]. PAR-1 is activated when
serine proteases such as thrombin or plasmin cleave the
N-terminus at Arg41, revealing a new N-terminus that
acts as a tethered ligand to activate receptor signaling
[4,5]. PAR-1 signals through multiple G-proteins,
including Gi, Gq, and G12/13 [5-7], and is highly
expressed in astrocytes throughout the CNS [8-10], and
differentially expressed in neuronal subpopulations in
discrete regions, including granule cell layer of dentate
gyrus [8,11,12]. Activation of PAR1 leads to profound
changes in astrocyte function, such as the proliferation
[13-15] that underlies glial scar formation in response to
penetrating head wound [16]. Activation of astrocytic
PAR1 also triggers the release of glutamate and subse-
quent potentiation of neuronal NMDA receptors sec-
ondary to depolarization-induced relief of Mg2+ block
[9,16,17]. In the present study, we have investigated the
functional expression of PAR1 in granule cells of the
dentate gyrus. We show that PAR1 activation leads to
granule cell depolarization and potentiation of synapti-
cally-activated NMDA receptor function.
Results
PAR1 expression in dentate granule cells
Multiple studies indicate that PAR1 mRNA is expressed in
both neurons and glia in a variety of brain regions [11,12].
Functional evidence exists for PAR1 expression in brain
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regions expressing PAR1 mRNA, such as the cortex, basal
ganglia, and hippocampus [16-20]. PAR1 immunoreactiv-
ity has not previously been reported in the dentate gyrus
[21], although in situ hybridization studies suggest PAR1
mRNA is expressed in the dentate [8,9] and injury stimu-
lates dentate microglial proliferation that can be mimicked
by PAR-1 activation [22]. To explore the potential role of
PAR1 in the dentate gyrus, we evaluated the protein
expression level of PAR1 using immunohistochemistry.
Immunostaining with thrombin receptor polyclonal anti-
body (S-19; see Methods) showed that PAR1 was
expressed in the outer layer of dentate granule cells in
wild type mouse (Figure 1A~C). Immunoreactivity could
also be observed in a subset of cells within the hilar region,
as well as within the neuropil in the dentate molecular
layer. To evaluate the specificity of thrombin receptor
polyclonal antibody (S-19), we performed western blotting
in cultured astrocyte transfected with scrambled shRNA
or PAR1 shRNA. The efficiency of knockdown by PAR1
shRNA has been previously reported [23]. Immunoblot-
ting showed that PAR1 shRNA reduced a single band on
the western blot using S19, which we interpret to be
PAR1. Immunocytochemistry with the thrombin receptor
polyclonal antibody (S-19) showed that shRNA for PAR1
significantly down-regulated PAR1 immunoreactivity in
cultured astrocytes (Figure 1E), suggesting that the anti-
body is selective for PAR1. To further investigate the
expression pattern of PAR1 in the dentate gyrus, we per-
form immunostaining using another thrombin receptor
antibody (monoclonal WEDE15) that has been previously
characterized [8] (Figure 1F~G). Immunoblotting with the
thrombin receptor antibody (WEDE15) shows single band
of PAR1 (66 kDa) in platelets (not shown) and brain tissue
(Figure 1G), suggesting the antibody selectively labels
PAR1. WEDE15 staining was apparent in dentate granule
cells (n = 3 separate experiments), and blocked by peptide
matching the epitope (data not shown). When we checked
the specificity of the antibodies, there was no staining for
PAR1 if the primary or secondary antibody was omitted
(data not shown). Thus, immunostaining using 2 different
antibodies shows similar expression pattern of PAR1 in
the dentate gyrus. These data suggest that PAR1 protein is
expressed in the dentate gyrus.
PAR1 activation in acutely dissociated dentate neurons
increases intracellular [Ca2+]
Activation of PAR1 can initiate signaling through Gai/o-,
Gaq/11-, and Ga12/13-coupled pathways [5,7]. To test
whether PAR1 activation induces an increase in intracel-
lular Ca2+ concentration in glia and neurons from the
dentate gyrus, we performed Ca2+ imaging in acutely
dissociated cells from the dentate that were subse-
quently loaded with the Ca2+-sensitive dye Fluo3-AM
(Figure 2A). Acute dissociation ensures representative
proportions of glia and neurons, and avoids changes in
PAR1 expression that could artifactually occur under
culture conditions. Fluo-3 fluorescence intensity was
increased in over half of the individual acutely disso-
ciated cells by the application of TFLLR or NMDA (Fig-
ure 2B). Previously, we have shown that TFLLR and
thrombin did not increase intracellular Ca2+, and gluta-
mate was not released by TFLLR in cultured PAR1-/-
mouse astrocytes [17]. This set of results indicates a
selective action of TFLLR and thrombin on PAR1.
Responses to NMDA were used to distinguish between
neuronal and non-neuronal cells. Four groups of cells
were categorized by Ca2+ responses induced by treat-
ment of TFLLR and NMDA (Figure 2C). We found that
86 of 248 NMDA-insensitive cells responded to the
PAR1 agonist TFLLR with an increase in intracellular
Ca2+, which we interpret to be glial cells. In addition, 19
of 144 NMDA-responsive cells, which we interpret to be
neurons, showed a TFLLR-induced increase in intracel-
lular Ca2+ (Figure 2D). Most of these cells had cell body
diameter of less than 10 μm, consistent with the size of
dentate granule cells (Figure 2A, e.g. cell #4). These
results indicate that PAR1 activation leads to an increase
in intracellular Ca2+ in both small neurons from the
dentate gyrus as well as non-neuronal cells. Further-
more, these results are consistent with a number of pre-
vious reports suggesting that thrombin stimulates Ca2+
mobilization in both neurons and glia [8,10,15,16,24-27].
PAR1 activation depolarizes dentate gyrus in wild type but
not in PAR1 -/- mice
To determine whether PAR1 activation alters neuronal
function in the dentate, we performed voltage-sensitive
dye imaging in the dentate gyrus of mouse hippocampal
slices loaded with the voltage-sensitive dye di-4-ANEPPS
and treated with 0.5 μM TTX to block action potential
generation and propagation (Figure 3A~B). Bath applica-
tion of the PAR1 agonist TFLLR decreased the intensity
of di-4-ANEPPS fluorescence throughout the dentate
gyrus, which we interpret to reflect membrane depolari-
zation both in cell body as well as in neuronal processes
(Figure 3C). By contrast, TFLLR had minimal effect on
di-4-ANEPPS fluorescence in hippocampal slices from
PAR1-/- mice (Figure 3D). The extent of changes di-4-
ANEPPS fluorescence was significantly higher in wild-
type compared to PAR1 -/- mice (p < 0.05, unpaired t-
test, n = 4-5). These data are consistent with the idea
that activation of PAR1 in the dentate can lead to depo-
larization of granule cells in the dentate gyrus.
PAR1 activation triggers action potential generation in a
subset of dentate granule cells
We subsequently performed whole cell current clamp
recording from dentate granule cells in hippocampal
slices to investigate whether individual neuronal
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Figure 1 Immunohistochemistry reveals that PAR1 receptor is expressed in dentate granule cells. A, B, C) Image of dentate in a thin
section from a C57Bl/6 mouse, immunostained with thrombin receptor polyclonal antibody (S-19, Santa Cruz). Red indicates DAPI staining (A)
and green indicates PAR1 immunostaining (B). PAR1-immunoreactivity is clearly expressed in the dentate granule cell layer (C); scale bar: 50 μm.
Data are representative of three different experiments from two different mice. D) Western blot of PAR1 with thrombin receptor polyclonal
antibody (S-19, Santa Cruz) in cultured astrocytes transfected with scrambled shRNA or PAR1 shRNA. 66 kDa PAR1 and 50 kDa actin bands are
presented. This experiment was performed three times from three different mice. E) Immunocytochemistry of PAR1 with thrombin receptor
polyclonal antibody (S-19, Santa Cruz) in cultured astrocytes. Green indicates cultured astrocytes transfected with PAR1 shRNA. Magenta shows
GFAP, a marker for all GFAP-positive astrocytes. Red represents PAR1 immunostaining. The arrow indicates a cultured astrocyte that expresses
PAR1 shRNA, whereas the arrowhead indicates an astrocyte without expression of shRNA. Staining in cultured astrocyte was performed in
permeabilized conditions. This experiment was performed three times from three different mice. Scale bar is 50 μm. F) Immunostaining with
PAR1 antibody (WEDE15) in the dentate gyrus using DAB staining; scale bar is 150 μm. G) Western blot of PAR1 with PAR1 monoclonal antibody
(WEDE15, Immunotech) in mouse whole brain homogenates. A single band corresponding to the predicted molecular weight of PAR1 (66 kDa)
was observed.
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Figure 2 PAR1 activation induces increase in intracellular [Ca2+] in a subpopulation of acutely dissociated dentate neurons, as well as
non-neuronal cells. A) Microphotographs of acutely dissociated cells from the dentate gyrus; scale bar is 10 μm. B) Ca2+ imaging traces for
cell #0, #4, and #19 as shown in A. Cells were exposed to 30 μM TFLLR and 100 μM NMDA at the indicated times. Y axis indicates intensity of
changes in pixel changes. C) Total percentages of responsive cells are expressed as percent of total cells. D) The response to NMDA was used to
categorize the cell as neuronal or non-neuronal. The bar graph indicates the percent of TFLLR-responsive cells expressed as percent of total
number of neurons or non-neurons. This experiment was performed from five different mice.
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function was detectably influenced by PAR1 activation.
Individual dentate granule neurons were visually iden-
tified using Normarski optics, recorded using patch
clamp methods, and evaluated under current clamp for
action potential generation in response to depolarizing
current injection to verify that they were neurons (Fig-
ure 4A, B). The granule cells had a mean resting
potential of -70 ± 1 mV and an input resistance of 383
± 34 MOhm (n = 14). Resting cells did not sponta-
neously fire action potentials. Activation of PAR1 by
application of 30 μM TFLLR induced a clear depolari-
zation of more than +3 mV in 7 of 14 granule cells;
the distribution of the change in membrane potentia-
tion was not normally distributed. On average, there
was a +8.5 mV depolarization during the application of
TFLLR, which was statistically significant (Wilcoxon
rank sign test, p < 0.001). Notably, there was a promi-
nent increase in action potential generation in several
of the cells showing greater than 3 mV depolarization
(Figure 4C, D). The relative proportion of cells that
depolarized by more than 3 mV (50%) is higher than
that of acutely isolated NMDA-response cells that
express functional PAR1 (13%), suggesting that PAR1-
mediated granule cell depolarization may involve both
intraneuronal signaling in addition to PAR1-mediated
astrocytic release of glutamate. These results indicate
that PAR1 can control neuronal firing and membrane
potential in a subset of dentate granule neurons, thus
could play a key role in controlling neuronal
excitability.
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Figure 3 Voltage-dye recordings show that PAR1 activation depolarizes the dentate in hippocampal slices from wild type but not in
PAR1-/- mice. A) Normarski image of mouse dentate within a hippocampal slice, loaded with the voltage-dye, di-4-ANEPPS and bathed in TTX
(0.5 uM). Scale bar is 100 μm. B) Threshold-modified fluorescence voltage-dye image superimposed on a Normarski image of mouse dentate
gyrus before 30 μM TFLLR was added. C) During application of 30 μM TFLLR, the entire dentate region becomes depolarized, represented by
yellow to red colors. D) Average traces of wild type and PAR1-/- dentate from regions of interest over the cell body layer show that wild type
dentate exhibits significantly greater depolarization, compared to the PAR1-/- dentate (p < 0.05, t-test at 55 sec). The experiment was performed
from two different mice respectively.
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PAR1 activation increases NMDA receptor-mediated
EPSPs in dentate granule cells
To assess the effects of PAR1 activation on synaptic
transmission, we measured EPSPs in mouse dentate
granule cells in response to perforant path stimulation.
We measured the EPSP waveform using voltage-sensi-
tive dye (di-4-ANEPPS) imaging of hippocampal slices,
which circumvents potential artifacts associated with
dialysis of the intracellular solution that might confound
PAR1 signalling within dentate granule cells. The per-
forant path was electrically stimulated using a monopo-
lar platinum electrode (see Methods), and dye
fluorescence intensity change was recorded using a high
speed camera with a frame transfer rate of 1 kHz (Fig-
ure 5A~B). A region of interest in the middle of the
dentate molecular layer was selected at which to record
the EPSP waveform, and the time course of intensity
changes of several pixels recorded as a function of time
(Figure 5B). The resulting waveform had the hallmark
features of EPSP recorded with an intracellular pipette,
but without the disturbance on intracellular signaling
pathways associated with impalement and potential dia-
lysis of the neuron.
We initially measured non-NMDA receptor-mediated
EPSPs in the presence of bicuculline to block GABAA
receptors. We subsequently supplemented the recording
solution with 10 μM CNQX and reduced the extracellu-
lar Mg2+ to 5 μM to isolate the NMDA receptor compo-
nent of the evoked EPSPs. Following recording of EPSPs
during a control period, we applied 30 nM thrombin to
activate PAR1 to slices while recording the pharmacolo-
gically-isolated NMDA receptor-mediated component of
the evoked EPSP. We found that PAR1 activation by
thrombin increased the amplitude of the NMDA recep-
tor-mediated EPSP (Figure 5B, D; 137 ± 14% of control;
p < 0.009, paired t-test; n = 12), whereas the amplitude of
the AMPA receptor-mediated EPSP was only minimally
altered by thrombin (data not shown; 113 ± 5% of con-
trol, p < 0.03, paired t-test; n = 9).
To confirm the result we obtained imaging voltage-
sensitive dye imaging, we performed field potential
recordings in the dentate molecular layer of hippocam-
pal slices in response to stimulation of the perforant
path. To isolate NMDA receptor-mediated field EPSP,
2 μM CNQX was added and concentration of Mg2+ was
reduced to 0.1 mM. PAR1 activation by 30 nM
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Figure 4 Whole-cell recordings of dentate granule cells show that PAR1 activation causes depolarization in an individual neuron. A)
Image of a visually-identified dentate granule cell, patched under whole-cell configuration. Scale bar is 10 μm. B) The cell was injected with
current as indicated to induce action potentials. Current was injected from -60 pA to 60 pA. C) The cell was subsequently challenged with 30
μM TFLLR, which induced a slow depolarization that drove the cell to fire action potentials repetitively. D) Out of 14 cells, the 7 neurons that
showed spike firing activity had an average depolarization of 11.5 ± 3.5 mV (mean ± SEM), induced by TFLLR. The internal solution contained K-
gluconate (see Methods).
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thrombin significantly increased the amplitude of field
EPSPs compared to slices recorded in ACSF alone (Fig-
ure 5C~D; p < 0.05, unpaired t-test; n = 12-13). This
result is consistent with data from voltage-dye record-
ings, and confirms that PAR1 activation can enhance
the NMDA component of excitatory transmission at the
perforant path-granule cell synapse.
Discussion
The most important finding of this study is that PAR1
activation induces both an increase in intracellular Ca2+
and depolarization accompanied by spike firing in a sub-
set of dentate granule neurons. In addition, PAR1
activation enhances the NMDA receptor component of
the perforant path-granule cell EPSP in the dentate
gyrus. The sum of these actions will be to enhance both
the excitability of the dentate gyrus and the excitatory
drive reaching the hippocampus. These data provide the
first description of the functional effects of PAR1 activa-
tion on the dentate granule neurons.
Previous immunohistochemical studies have shown
that PAR1 protein is expressed primarily in human
astrocytes of white and gray matter in the cortex, hippo-
campus, caudate, putamen, and cerebellum [8]. By con-
trast, larger pyramidal neurons of the hippocampus and
cortex show only modest PAR1 immunoreactivity in
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Figure 5 Voltage-dye recordings demonstrate that PAR1 activation causes an increase in amplitude of NMDA receptor-mediated EPSP
in dentate of hippocampus. A) Bright field image of mouse dentate hippocampus, loaded with the voltage-dye, di-4-ANEPPS. The boxed
region is imaged during electrical stimulation with a stimulating electrode, as shown. Scale bar is 300 μm. B) The left panel is voltage-dye image
during a synaptic response in the presence of 10 μM bicuculline, and 10 μM CNQX. Changes in intensity correspond to degree of voltage
changes and are represented in pseudo-color. The scale bar is 50 μm. The traces (right panel) show the time course of intensity changes
averaged from pixels in a selected region of interest over the cell body layer. The time courses for each condition are overlaid and plotted; all
waveforms are corrected using a baseline slope from unstimulated records to account for time-dependent changes in voltage dye fluorescence.
The experiment was performed from four different mice, respectively. C) The time course of normalized field EPSP amplitude in the presence of
2 μM CNQX. Black trace represents the thrombin treated slice. Blue trace represents control slice. Slices were from six mice (control) and eight
mice (thrombin). D) Similar experiments are repeated and the results are summarized in this bar graph. Bar graphs show % increase over control
of NMDA EPSP by voltage dye imaging or field recording. The average % increase is expressed as mean ± SEM (* p < 0.05).
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human brain [8]. Our immunocytochemical data indi-
cate that PAR1 is also expressed in the dentate granule
neurons, consistent with in situ hybridization data sug-
gesting PAR1 expression in dentate gyrus [11,12]. More-
over, the immunohistochemical data are consistent with
electrophysiological recordings from hippocampal slices,
in which a subset of granule neurons show functional
responses to PAR1 activation.
PAR1 activation and Ca2+ increase
The PAR1 receptor is functionally linked to multiple G-
proteins, including Gaq/11. PAR1 activation leads to a
cleavage of PIP2 by phospholipase (PLC) to generate 1,
2-diacylglycerol (DAG) and inositol 1, 4, 5 triphosphate
(IP3). Activation of IP3 receptors increases intracellular
Ca2+. Thus, the observation that a subset of NMDA-
responsive acutely dissociated cells shows an increase in
intracellular Ca2+ in response to PAR1 activation sug-
gests that dentate neurons express PAR1 that is func-
tionally coupled to Gaq/11. These data are consistent
with previous study of cultured neurons from the hippo-
campal formation, that included the dentate gyrus [28].
In addition, data obtained from acutely dissociated cells
studied here strongly suggest that PAR1 is functionally
expressed in intact tissue, since the acute dissociation
protocol eliminates potential confounds associated with
culture conditions that could alter PAR1 expression.
However, neuronal data from slice recordings showing
strong depolarization following PAR1 activation raises
the possibility that some of the increase in intracellular
Ca2+ we observe may have been supplemented by trans-
membrane flux through voltage gated Ca2+ channels
that could be activated by neuronal depolarization.
There is another possible mechanism of Ca2+ increase
by PAR1 activation. It has been reported that Ca2+
influx from extracellular region elicits Ca2+ induced Ca2
+ release (CICR) through ryanodine receptors in the
dentate gyrus [29]. Therefore, Ca2+ induced Ca2+ release
may contribute to PAR1 induced Ca2+ increase in the
dentate gyrus.
PAR1 activation and neuronal excitability
The depolarization of dentate granule cells by PAR1
activation could reflect the sum of multiple mechanisms.
It has been suggested that activation of the H1 receptor,
which is linked to Gaq signalling pathways, induces
neuronal depolarization by blocking background K+
channel [30-32]. PAR1 could engage this same pathway
in a subset of granule cells to lead to modification of K+
channel activity and subsequent depolarization. In addi-
tion, PAR1-mediated increases in intraneuronal Ca2+
could enhance the activation of a non-selective cation
current, such as those mediated by TRP channels [33].
We and others have also described a mechanism by
which PAR1 activation in astrocytes triggers release of
~1 μM glutamate into the extracellular space [9,17,34].
This astrocyte-derived glutamate release has also been
shown to activate NMDA receptors on neurons, which
can lead to neuronal depolarization. Thus, multiple pos-
sible mechanisms exist by which PAR1-mediated
increases in granule cell intracellular Ca2+ could depo-
larize these neurons.
PAR1 activation increases the synaptically-evoked
NMDA receptor-mediated component of the EPSP pro-
duced by perforant path stimulation. The PAR1-trig-
gered enhancement in the evoked EPSP was blocked by
APV and higher Mg2+ concentration (data not shown),
suggesting that depolarization-induced relief of Mg2+
blockade may be required for thrombin-induced poten-
tiation of NMDAR. Several previous studies have
described a new mechanism by which astrocytic PAR1
activation can evoke Ca2+-dependent glutamate release
from astrocyte that subsequently controls synaptic
NMDA receptor function in neurons [9,17]. Further-
more, D-seine, an NMDAR glycine site agonist, released
from astrocyte in a Ca2+ dependent manner can also
regulate the function of NMDA receptor [35]. The
depolarization of dentate granule neurons will reduce
Mg2+ blockade of NMDA receptor, resulting in an
apparent enhancement of the synaptic NMDA receptor
response in the presence of Mg2+. Our data are consis-
tent with the idea that this mechanism is operational in
the dentate gyrus.
In addition PAR1 activation could also lead to the
generation of lysophosphatidic acid and arachidonic
acid, a mechanism that previously has been described in
platelets and endothelial cells [36]. Both of these lipid
signaling molecules are highly mobile and capable of
mediating intercellular signaling. Although it is not yet
known whether PAR1 activation in dentate gyrus can
trigger formation of these lipids, release of lysophospha-
tidic acid or arachidonic acid could potentially play a
role in the effects described here. Whereas arachidonic
acid can directly potentiate neuronal NMDA receptor
function [37], lysophosphatidic acid has been suggested
to enhance NMDA receptor function through depolari-
zation-induced relief of Mg2+ block [38]. Further work
is needed to determine the relative contribution of these
(and other) mechanism(s) to PAR1-induced depolariza-
tion of dentate granule cells.
Function of PAR1 in physiological and pathological
conditions
The physiological role of PAR1 receptors in normal
synaptic transmission has not been extensively investi-
gated. Interestingly, tissue plasminogen activator (tPA),
which is known to convert plasminogen to plasmin, can
influence long-term potentiation, an NMDA receptor-
Han et al. Molecular Brain 2011, 4:32
http://www.molecularbrain.com/content/4/1/32
Page 8 of 12
dependent cellular model of learning and memory [39].
Several lines of evidence indicate that plasmin can regu-
late the function of NMDA receptors through PAR1
activation [34,40]. Similarly, PAR1 -/- mice show defi-
ciencies in emotional learning, an NMDA receptor-
dependent process [41]. Taken together, these results
suggest that tPA-activated plasmin could be an endo-
genous ligand for PAR1 receptor [20] that leads to
PAR1-mediated tuning of NMDA receptor function in a
manner relevant for synaptic plasticity and behavior. By
potentiating synaptic NMDA receptor, we predict that
PAR1 activation would decrease threshold for stimuli
needed to trigger changes in synaptic strength. Consis-
tent with this idea, multiple studies have shown that
PAR1 activation can influence the threshold for LTP
[42,43]. In addition, sufficient thrombin can enter brain
tissue in pathological conditions such as ischemia or
hemorrhage and activate PAR1 receptor, which in multi-
ple animal models has been shown to enhance neuronal
damage [44-54]. During ischemia, the harmful actions of
PAR1 require NMDA receptor function [55]. Our data
are consistent with the idea that PAR1 activation in the
dentate gyrus can enhance neuronal excitability, which
may promote NMDA-receptor mediated excitotoxicity
in neurons [43,45,56].
Methods
Immunohistochemistry
Wild type C57Bl/6 mice were deeply anesthetized by 2%
avertin (20 μl/g) and transcardially perfused with 4%
paraformaldehyde. All procedures involving the use of
animals were reviewed and approved by the Emory Uni-
versity IACUC. The brain was isolated, and cut at 30
μm with a cryostat. Sections were blocked in 0.1 M PBS
containing 0.3% triton X-100 (Sigma) and 2% serum
from species of the secondary antibody for 1 hr. Throm-
bin receptor goat polyclonal antibody against mouse
PAR1 N-terminal (S-19; Santa Cruz; catalog # sc-8204)
was applied at 1:20 dilution (S-19) and incubated over-
night at 4°C. After overnight incubation, the sections
were washed three times in phosphate-buffered saline
(PBS) and then incubated in secondary antibody (Alexa
555 donkey anti-’goat IgG; Invitrogen; 1:400) for 2 hr.
After three rinses in PBS, the sections were mounted on
slide glass. Images were acquired on an Olympus Fluo-
view FV1000 confocal microscope and analyzed using
Image J software.
Adult Sprague-Dawley rats were given a lethal dose of
pentobarbital (150 mg/kg) and subsequently transcar-
dially perfused with cold 3% paraformaldehyde (4°C).
The brain was subsequently isolated, post-fixed in 3%
paraformaldehyde for 24 hrs, cryoprotected in 30%
sucrose and 0.1 M phosphate, frozen on dry ice, and cut
at 40 μm on a sliding microtome. The sections were
washed 6 times (10 min each) in Tris-buffered saline
(TBS), and incubated in 3% H2O2 to block endogenous
peroxidases. The sections were washed 3 times (10 min
each) in TBS plus 0.1% Triton X-100, followed by incu-
bation with the monoclonal WEDE15 PAR1 antibody (5
μg/ml, Immunotech-Coulter; epitope residues 51-64 in
exon2, KYEPFWEDEEKNES) in 10% horse serum in
TBS overnight at 4°C. The sections were washed 3 times
(10 min) in TBS and incubated for 1 hr in biotin-conju-
gated rat anti-mouse secondary antibody (1:200) in 10%
horse serum in TBS plus 0.1% Triton X-100. The sec-
tions were washed 3 times (10 min) in TBS and the avi-
din-biotin complex method was used to detect antigen
signal. 3,3’-diamino benzidine tetrachloride was used to
visualize the final product. Immunostained sections
were mounted on slides and visualized using bright field
microscopy; data were obtained from three independent
experiments, and showed similar staining patterns. No
immunoreactivity could be detected when either the pri-
mary or secondary antibody was omitted from the pro-
tocol (data not shown). Inclusion of a peptide matching
the epitope blocked staining in dentate gyrus (data now
shown).
Primary astrocyte culture
Cultured astrocytes were prepared from P0~P3 postna-
tal mice. The cerebral cortex was dissected free of
adherent meninges, minced and dissociated into single
cell suspension by trituration. Dissociated cells were pla-
ted onto 12 mm glass coverslips coated with 0.1 mg/ml
poly D-lysine. Cells were grown in DMEM supplemen-
ted with 25 mM glucose, 10% heat-inactivated horse
serum, 10% heat-inactivated fetal bovine serum, 2 mM
glutamine, and 1000 units ml-1 penicillin-streptomycin.
Cultures were maintained at 37°C in humidified 5%
CO2-containing atmosphere. Astrocyte cultures prepared
in this way were confirmed by GFAP staining using
anti-GFAP antibody (Millipore; catalog # AB5541;
1:1000)
Western blotting
Adult rat and mouse brain regions were dissected,
homogenized in ice cold RIPA buffer (phosphate buf-
fered saline, 1% Igepal CA-360, 0.5% Na-deoxycholate,
0.1% SDS) containing the protease inhibitor 1 mM
PMSF. The membranes were stored at 20°C. Whole
cell lysate was incubated with 2% SDS, 62.5 mM Tris,
10% glycerol, 5% b-mercaptoethanol, and 0.05% bro-
mophenol blue for 5 minutes at 100°C. 40 μg of pro-
tein for each sample was loaded and separated on 10%
polyacrylamide gels, then transferred to PVDF mem-
branes. Blots were blocked with TBS containing 1%
Tween-20 and 5% skim milk for 30 min at RT, and
incubated with a goat polyclonal antibody against
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thrombin receptor (S-19; Santa Cruz; 1:300) overnight
at 4°C. After washing with TBS plus Tween, blots were
incubated with HRP-conjugated anti-goat secondary
antibody (Santa Cruz; 1:3000), followed by washing
and the detection of immunoreactivity with enhanced
chemiluminescence (ECL; Amersham). The same blots
were re-probed with a rabbit monoclonal antibody
against a-actin (Sigma; catalog # A2066; 1:2000) to
confirm equal loading.
Ca2+ Imaging
The dentate gyrus was dissected from 400 μm horizon-
tal rat brain slices, incubated with 1 mg/ml trypsin for
20 min, and then mechanically dissociated using vibra-
tion with fire polished glass pipettes. Dissociated cells
are plated on glass coverslips, and loaded with 5 μM
Fluo3-AM for 30 min for Ca2+ imaging. External solu-
tion contained (in mM) 150 NaCl, 10 HEPES, 3 KCl, 2
CaCl2, 1 MgCl2, 22 sucrose, 10 glucose; pH adjusted to
7.4 and osmolarity to 325 mOsm (23°C). 30 μM
TFLLR or 100 μM NMDA were applied to the cells
Fluo3 was excited by a 100 W mercury lamp and the
timing was controlled by a high speed shutter (Uni-
blitz). Images were acquired and analyzed by custom
software.
Whole-cell patch clamp recording of dentate granule cells
Young mice (C57/B16, age P15-20) were deeply anaes-
thetized with isoflurane until cessation of breathing and
subsequently decapitated. The brain was rapidly
removed and submerged in an ice-cold oxygenated arti-
ficial cerebrospinal fluid (ACSF) composed of (in mM)
130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25 NaH2PO4, 1
CaCl2, 3 MgCl2, 10 glucose at pH 7.4, and was bubbled
with 5% CO2/95% O2. Transverse slices (300 μm) were
prepared with a Leica vibratome, and incubated in a
chamber with oxygenated ACSF at room temperature
for 1 hr before use. The internal solution was comprised
of (mM) 140 K-MeSO4, 10 HEPES, 7 NaCl, 4 Mg-ATP,
and 0.3 Na-GTP. The recording ACSF solution was
composed of (in mM) 130 NaCl, 24 NaHCO3, 3.5 KCl,
1.25 NaH2PO4, 1.5 CaCl2, 1.5 MgCl2, and 10 glucose at
pH 7.4 and was bubbled with 5% CO2/95% O2 (23°C).
Visually guided whole-cell patch recordings were
obtained from dentate granule neurons in current clamp
configuration using an Axopatch 200A (Axon instru-
ments, Union City, CA, USA) and a patch pipette of
5~7 MΩ resistance. Electrophysiological properties were
monitored before and at the end of the experiments.
Series and input resistances were monitored throughout
the experiment using a -5 mV pulse. Recordings were
considered stable when the series and input resistances,
resting membrane potential and stimulus artifact dura-
tion did not change > 20%.
Voltage Dye Imaging
400 μm thick transverse hippocampal slices of mouse
brain were loaded with the voltage dye, di-4-ANEPPS
(D-1199, Molecular Probes Inc.) at 3 mg/ml for 10-30
min. The voltage sensitive dye (VSD) was dissolved into
a 2:1 mixture of ethanol and 10% Cremophor EL
(Sigma), a castor oil derivative, which was used as a dye
stock solution (3.3 mg of VSD/ml mixture). The dye
stock solution was mixed with a 1:1 mixture of ACSF
and fetal bovine serum (Sigma) to a final VSD concen-
tration of 0.2 mM and was used as staining solution.
Each slice was stained with 100 ml of the staining solu-
tion by gently squirting the solution into the plexiglass
ring, following incubation in a humidified chamber for
25 min. The slices were rinsed with ACSF by dipping it
together with the plexiglass ring [57]. Images (resolu-
tion: 60 × 90 pixels) were acquired at 100 Hz (10 ms
sample interval) for 65 seconds (23°C), using MiCam
camera system (BrainVision, Japan). This high speed
camera system converted the changes in intensity to dif-
ferent colors. Di-4-ANEPPS decreases its fluorescence
intensity when the membrane depolarizes. A 20× water
objective (N.A. = 0.95, Olympus) was used to acquire
the images. The dye was excited at 510 nm and emitted
light that was detected at 590 nm.
Field Recording
400 μm transverse hippocampal slices were prepared
from 21-28 day old mice, as described above. Slices (400
μm thick) were placed in a submerged chamber super-
fused with oxygenated ACSF (see above). Field poten-
tials were recorded with a micropipette (5-10 MOhm)
filled with HEPES-buffered saline positioned in the den-
tate gyrus molecular layer. Field EPSPs were evoked at
room temperature (25°C) by perforant path stimulation
(0.1 ms, 10-100 μA) using a monopolar stimulating elec-
trode. The NMDA component was isolated by recording
in 0.1 mM Mg2+ and 10 μM CNQX. NMDA-component
field EPSPs were digitized at 10 kHz, and the field EPSP
amplitude quantified.
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